Skip to main content
MHRA logo
Clinical Practice Research Datalink
UK data driving real-world evidence
  • Home
    • Senior management team
    • Job vacancies
  • News
  • Public
    • Safeguarding patient data
    • CPRD case studies
    • Approved studies
    • Data use audits
    • Data protection notice
  • Data
    • Primary care data
    • Linked data
    • Synthetic data
    • Data highlights
    • DOIs
    • Research applications
      • Data access
      • Committee members
  • Our services
    • Interventional studies
      • CPRD SPRINT
      • CPRD PROVE
    • Observational research
      • CPRD-enabled research
    • Pricing
  • General Practitioner
    • GP practice joining form
    • Quality improvement reports for GPs
    • Safeguarding patient data
    • How your data makes a difference
    • What we do with information about you
  • Research
    • Approved studies
    • Bibliography
  • Log in

Breadcrumb

  1. Home

Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety

Author
S. Suissa
S. Dell'Aniello
P. Ernst
Keywords
Administration, Inhalation
Adrenal Cortex Hormones/therapeutic use
Adrenergic beta-2 Receptor Agonists/therapeutic use
Bronchodilator Agents
Budesonide/adverse effects
Fluticasone/therapeutic use
Humans
Middle Aged
*Pneumonia/epidemiology/etiology
*Pulmonary Disease, Chronic Obstructive
COPD exacerbations
New-user cohort design
pneumonia
inhaled corticosteroids
long-acting bronchodilators
observational research
real-world evidence
Year of Publication
2022
Journal
Copd
Volume
19
Number of Pages
109-117
ISBN Number
1541-2563
Accession Number
35385359
DOI
10.1080/15412555.2022.2035705
  • DOI
  • Google Scholar
  • BibTeX
  • EndNote X3 XML
  • EndNote 7 XML
  • Endnote tagged
  • Marc
  • RIS

Stethoscope

GP practices - Join today

Safety studies logo

Researcher log in

stick people holding hands

Research applications

LinkedIn
Twitter
Youtube
NIHR logo

Support links

  • Accessibility statement
  • Contact
  • Privacy notice
  • Terms and conditions
  • Login
Crown Copyright © 2022 | All Rights Reserved